Social Anxiety Disorder Research Study

Study to Assess the Safety, Tolerability, and Efficacy of NTX-1472, a V1a Receptor Antagonist, in Adults with Social Anxiety Disorder

Social Anxiety Disorder is more than just feeling shy. It can involve an intense, persistent fear of being watched and judged by others. This fear can affect work, school, and your other day-to-day activities.

Researchers are evaluating an investigational medication as a possible treatment for Social Anxiety Disorder. Take our pre-screener to see if you qualify.

You may qualify if you are:

• An adult aged 18-65

• Diagnosed with or experiencing symptoms of Social Anxiety Disorder

• Experiencing symptoms such as intense fear of social situations or being watched/judged.

You may NOT qualify if you:

• Have 2 failed attempts at treating the Social Anxiety with FDA approved medications or has 1 failed attempt at treating with benzodiazepine.
• Have current diagnosis of any of the following:
  • Adjustment disorder
  • Attention deficit/hyperactivity disorder
  • Autism spectrum disorder
  • Body dysmorphic disorder
  • Major depressive disorder
  • Panic disorder
  • Personality disorder
  • Post-traumatic stress disorder
• Have past or current diagnosis of any of the following psychiatric condition(s):
  • Bipolar disorder
  • Feeding and eating disorder (in adulthood)
  • Obsessive-compulsive disorder
  • Schizophrenia spectrum or other psychotic disorder
  • Substance use disorder (within 12 months of Screening)
• Are using inhibitors of CYP3A4 (e.g., itraconazole, St. John’s wort, or phenytoin); Cannabidiol (CBD) or tetrahydrocannabinol (THC)-containing substances (by any route of administration), regardless of whether or not they are prescribed)

Not sure if you qualify? That’s okay.
A member of our recruitment team will review your medical history and medications with you to see if this study may be right for you.

• Advance Medical Knowledge: Help advance Social Anxiety Disorder medical research and play a crucial role in future treatments.

• Innovative Approach: Researchers are evaluating an investigational medication for its effectiveness at treating symptoms.

• Be a Partner: By joining, you’re not just a participant; you’re a vital contributor to the search for new treatment options.

Study Duration:
Up to 3.5 months

Study Visits:
Up to 6 clinic visits and 2 phone calls

Compensation:
Participants may receive compensation up to $1125